Edwards Lifesciences
1,310 hedge funds and large institutions have $59.5B invested in Edwards Lifesciences in 2022 Q1 according to their latest regulatory filings, with 126 funds opening new positions, 472 increasing their positions, 475 reducing their positions, and 117 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.64% less ownership
Funds ownership: 82.47% → 81.83% (-0.64%)
4% less funds holding in top 10
Funds holding in top 10: 27 → 26 (-1)
11% less capital invested
Capital invested by funds: $66.6B → $59.5B (-$7.03B)
Holders
1,310
Holding in Top 10
26
Calls
$289M
Puts
$189M
Top Buyers
| 1 | +$195M | |
| 2 | +$109M | |
| 3 | +$80.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$76.3M |
| 5 |
CI Investments Inc
Toronto,
Ontario, Canada
|
+$63.1M |
Top Sellers
| 1 | -$205M | |
| 2 | -$205M | |
| 3 | -$119M | |
| 4 |
Barclays
London,
United Kingdom
|
-$108M |
| 5 |
Two Sigma Investments
New York
|
-$99.8M |